Biomarkers in amyotrophic lateral sclerosis
Top Cited Papers
- 1 January 2009
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 8 (1) , 94-109
- https://doi.org/10.1016/s1474-4422(08)70293-x
Abstract
No abstract availableThis publication has 124 references indexed in Scilit:
- ALS and FTLD: two faces of TDP‐43 proteinopathyEuropean Journal of Neurology, 2008
- TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degenerationActa Neuropathologica, 2008
- Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Prognosis of amyotrophic lateral sclerosis with respiratory onsetJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosisNeuroscience Letters, 2007
- Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjectsAmyotrophic Lateral Sclerosis, 2007
- Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Plasma amino acids percentages in amyotrophic lateral sclerosis patientsNeurological Sciences, 2003
- Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosisJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1999